EyeGene Inc. (KOSDAQ:185490)
South Korea · Delayed Price · Currency is KRW 1,327.00
0.00 (0.00%)
At close: Feb 19, 2026
EyeGene Market Cap
EyeGene has a market cap or net worth of 56.67 billion as of February 20, 2026. Its market cap has decreased by -20.43% in one year.
Market Cap
56.67B
Enterprise Value
33.18B
Revenue
4.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,327.00
Market Cap Chart
Since November 16, 2015, EyeGene's market cap has decreased from 131.00B to 56.67B, a decrease of -56.74%. That is a compound annual growth rate of -7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 57.37B | -23.69% |
| Dec 30, 2025 | 75.18B | 8.64% |
| Dec 30, 2024 | 69.20B | -24.46% |
| Dec 28, 2023 | 91.61B | -15.21% |
| Dec 29, 2022 | 108.04B | -73.58% |
| Dec 30, 2021 | 408.92B | 175.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quratis | 84.00B |
| Parataxis Korea | 82.74B |
| HLB Pep | 76.58B |
| CHA Vaccine Research Institute | 72.40B |
| PanGen Biotech | 71.52B |
| Ark Solutions | 68.91B |
| SunBio,Inc. | 67.43B |
| NGeneBio | 54.39B |